Edmond DE Rothschild Holding S.A. raised its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,700 shares of the pharmacy operator’s stock after acquiring an additional 235 shares during the quarter. Edmond DE Rothschild Holding S.A.’s holdings in Walgreens Boots Alliance were worth $524,000 as of its most recent SEC filing.
A number of other institutional investors have also recently modified their holdings of WBA. Hudock Capital Group LLC raised its holdings in Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 6 shares in the last quarter. Reilly Financial Advisors LLC raised its holdings in Walgreens Boots Alliance by 7.9% during the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after purchasing an additional 100 shares in the last quarter. Orrstown Financial Services Inc. raised its holdings in Walgreens Boots Alliance by 14.1% during the second quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 213 shares in the last quarter. Founders Capital Management acquired a new stake in Walgreens Boots Alliance during the first quarter worth approximately $161,000. Finally, Hanson McClain Inc. raised its holdings in Walgreens Boots Alliance by 4.6% during the second quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock worth $156,000 after purchasing an additional 87 shares in the last quarter. Institutional investors own 63.58% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Edmond DE Rothschild Holding S.A. Purchases 235 Shares of Walgreens Boots Alliance, Inc. (WBA)” was published by Markets Daily and is the property of of Markets Daily. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The original version of this piece of content can be accessed at https://www.themarketsdaily.com/2017/11/13/edmond-de-rothschild-holding-s-a-purchases-235-shares-of-walgreens-boots-alliance-inc-wba.html.
A number of research firms have weighed in on WBA. Royal Bank Of Canada began coverage on shares of Walgreens Boots Alliance in a report on Tuesday, September 19th. They set an “outperform” rating and a $96.00 price objective on the stock. Needham & Company LLC reissued a “buy” rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a report on Saturday, September 16th. BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, September 12th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a report on Thursday, September 7th. Finally, UBS AG reaffirmed a “buy” rating and issued a $96.00 target price (down from $97.00) on shares of Walgreens Boots Alliance in a report on Wednesday, August 23rd. One analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $87.63.
Walgreens Boots Alliance, Inc. (WBA) opened at $70.99 on Monday. Walgreens Boots Alliance, Inc. has a one year low of $63.82 and a one year high of $88.00. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45. The company has a market cap of $71,667.88, a PE ratio of 13.92, a PEG ratio of 1.26 and a beta of 1.20.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The company had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. During the same quarter in the prior year, the company posted $1.07 EPS. The company’s quarterly revenue was up 5.3% compared to the same quarter last year. sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 5.55 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.25%. The ex-dividend date of this dividend is Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio is currently 42.33%.
Walgreens Boots Alliance declared that its board has authorized a share buyback program on Wednesday, October 25th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the pharmacy operator to reacquire shares of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s leadership believes its shares are undervalued.
In related news, Director John Anthony Lederer purchased 20,000 shares of the firm’s stock in a transaction on Thursday, October 26th. The stock was purchased at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the acquisition, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the transaction, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Corporate insiders own 13.50% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.